• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:201601021285706972   Update date: Mar. 24, 2025

Sekine Yoshitaka

セキネ ヨシタカ | Sekine Yoshitaka
Affiliation and department:
Job title: Assistant Professor
Research field  (1): Urology
Research theme for competitive and other funds  (7):
  • 2022 - 2025 神経内分泌細胞分化前立腺癌における脂質代謝を介した増殖メカニズムの基礎的検討
  • 2019 - 2022 Combination therapy of PARP inhibitor, statin and platinum-containing drug for prostate cancer
  • 2016 - 2019 Combination therapy with X-ray or heavy ion therapy and statin for prostate cancer
  • 2015 - 2018 Lipid and steroid metabolism and prostate cancer using imaging mass-spectrometry
  • 2013 - 2015 Effect of statins on de novo steroid synthesis pathways in androgen independent prostate cancer cells.
Show all
Papers (380):
  • Yoshitaka Sekine, Daisuke Oka, Akira Ohtsu, Hiroshi Nakayama, Takeshi Miyao, Yoshiyuki Miyazawa, Seiji Arai, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, et al. The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivo. BMC cancer. 2025. 25. 1. 521-521
  • Yoshitaka Sekine, Yuji Fujizuka, Shun Nakazawa, Yusuke Tsuji, Akira Ohtsu, Yoshiyuki Miyazawa, Seiji Arai, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, et al. Utility of Combining Prostate Health Index and Magnetic Resonance Imaging for the Diagnosis of Prostate Cancer. International journal of urology : official journal of the Japanese Urological Association. 2025
  • Yoshiyuki Miyazawa, Hiroshi Nakayama, Hidemasa Kawamura, Yuhei Miyasaka, Masahiro Onishi, Takuya Kaminuma, Yoshitaka Sekine, Hiroshi Matsui, Tatsuya Ohno, Kazuhiro Suzuki. Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study. Radiation Oncology. 2024. 19. 1
  • 大西 真弘, 河村 英将, 宮澤 慶行, 関根 芳岳, 小池 秀和, 松井 博, 鈴木 和浩, 大野 達也. 前立腺癌に対する重粒子線治療16回照射の長期治療成績. 日本癌治療学会学術集会抄録集. 2024. 62回. O24-2
  • 宮澤 慶行, 小池 秀和, 河村 英将, 岡 大祐, 久保 亘輝, 大西 真弘, 宮坂 勇平, 周東 孝浩, 関根 芳岳, 松井 博, et al. 傾向スコアマッチング法を用いたRARPと重粒子線治療後の性機能QOLスコア比較研究. 日本癌治療学会学術集会抄録集. 2024. 62回. O24-5
more...
MISC (98):
  • 大西真弘, 河村英将, 渋谷圭, 松井博, 関根芳岳, 宮澤慶行, 鈴木和浩, 大野達也. Re-evaluation of T Stage in Referred Prostate Cancer Patients through In-Hospital Joint Conferences. 泌尿器外科. 2024. 37. 8
  • 宮澤 慶行, 新井 誠二, 関根 芳岳, 鈴木 和浩. ASCO-GU 2021. Espoir : new voyage of prostate cancer / 「Espoir」編集委員会 編. 2021. 4. 1. 40-42
  • 鈴木和浩, 周東孝浩, 宮澤慶行, 新井誠二, 関根芳岳. Cardiovascular disease and androgen deprivation therapy for prostate cancer. 月刊泌尿器科. 2021. 13. 4
  • 宮澤慶行, 関根芳岳, 新井誠二, 鈴木和浩. Palliative surgical treatment for Castration Resistant Prostate Cancer patients. Prostate Journal. 2021. 8. 1
  • 宮澤慶行, 河村英将, 北田陽子, 関根芳岳, 新井誠二, 松井博, 鈴木和浩. リスクごとに考える 症例からみる前立腺がんの治療と看護 症例からみる前立腺がんの治療と看護 06 高リスク・超高リスク:放射線照射(重粒子線). 泌尿器Care & Cure Uro-Lo. 2021. 26. 3
more...
Lectures and oral presentations  (4):
  • High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.
    (AUA 106th annual Meeting 2011)
  • High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.
    (AUA 106th annual Meeting 2011)
  • High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism.
    (2010)
  • High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism.
    (2010)
Professional career (1):
  • Doctor of Medical Science (Gunma University)
Work history (6):
  • 2010/10 - 現在 Gunma University
  • 2008/06 - 2010/09 アメリカ国立衛生研究所 研究員
  • 2003/06 - 2004/05 足利赤十字病院泌尿器科
  • 2002/06 - 2003/05 伊勢崎市民病院泌尿器科
  • 2001/06 - 2002/05 原町赤十字病院泌尿器科
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page